Review
Copyright ©The Author(s) 2023.
World J Psychiatry. Nov 19, 2023; 13(11): 816-830
Published online Nov 19, 2023. doi: 10.5498/wjp.v13.i11.816
Table 1 Clinical outcomes of the 67 patients described in the case reports
Patient demographics
Values
Median age (yr)25 (1.5-85)
Male sex49.3
Poisoning exposure
Mean peak carbamazepine concentration in mg/L39.0 (17.7-93.8)
Clinical symptoms and signs
Respiratory depression47.8
Decreased consciousness100
Seizure20.9
Hypotension14.9
Dysrhythmias19.4
Treatment measure1
Supportive care9.0
Gastric lavage29.9
Multiple-dose activated charcoal58.2
Hemoperfusion22.4
Hemodialysis22.4
Continuous renal replacement treatment12.0
Plasma exchange and plasmapheresis4.5
Lipid resuscitation therapy4.5
Outcome
Recovery82.0
Sequelae12.0
Fatalities6.0
Table 2 Executive summary of recommendations for the treatment of carbamazepine poisoning
General statement
    The primary treatment for CBZ poisoning is GL
    A mainstay of treatment is multiple-dose activated charcoal
    ECTR is suggested in cases of severe CBZ poisoning
    Intermittent hemodialysis is the preferred ECTR for CBZ poisoning
    Lipid resuscitation therapy is an effective adjunctive treatment to ECTR
Supportive care
    Severe central nervous system depression requires endotracheal intubation
    To avoid masking subsequent seizures, short-acting neuromuscular blockers are recommended
    Isotonic crystalloid to correct hypotension should be considered first; when isotonic crystals do not work, direct-acting vasopressors can be applied
    QRS prolongation is treated with sodium bicarbonate
Management precautions
    GL is contraindicated when patients have impaired consciousness, recent surgery, no protection of airway, risk of gastrointestinal bleeding and perforation, and the potential for increased risk and severity of aspiration
    Multiple-dose activated charcoal should be used with caution in cases of an unprotected airway, presence of intestinal obstruction, or gastrointestinal tract not anatomically intact